Our discussions with the Federal Government have been focused on providing more choice for Australians to manage their diabetes, with FreeStyle Libre's revolutionary technology.
The November 2018 expanded funding announcement included FreeStyle Libre for the first time, and the Federal Government has just reiterated their intention to include the FreeStyle Libre Flash Glucose Monitoring System on the list of products subsidised under the expanded CGM funding scheme for new glucose monitoring devices. We also look forward to the Federal Government initiating the next steps towards subsidisation of FreeStyle Libre on the NDSS, outside of the expanded CGM funding.
FreeStyle Libre is used by over 1 million people globally across 46 countries. While we are in discussions with the Federal Government and the final decision rests with them, we are hopeful that Australia soon joins the list of 32 countries where FreeStyle Libre is already reimbursed. Years of clinical and real-world evidence show that when individuals living with diabetes use Abbott’s Flash Glucose Monitoring technology, they have both short and long-term benefits.
Bolinder J,et al.Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes a multicentre, non-masked, randomised controlled trial. The Lancet 2016.
Aijan, R., Insights from Real World Use of Flash Continuous Glucose Monitoring (2018, June). Symposium conducted at the conference for American Diabetes Association 78th Scientific Sessions, Orlando, FL., USA